- Home
- MOGU vs PMN Comparison
MOGU vs PMN Comparison
Compare MOGU & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- PMN
- Stock Information
- Founded
- MOGU 2011
- PMN 2004
- Country
- MOGU China
- PMN Canada
- Employees
- MOGU N/A
- PMN N/A
- Industry
- MOGU Business Services
- PMN Pharmaceuticals and Biotechnology
- Sector
- MOGU Consumer Discretionary
- PMN Health Care
- Exchange
- MOGU Nasdaq
- PMN Nasdaq
- Market Cap
- MOGU 19.8M
- PMN 22.3M
- IPO Year
- MOGU 2018
- PMN N/A
- Fundamental
- Price
- MOGU N/A
- PMN $0.48
- Analyst Decision
- MOGU
- PMN Strong Buy
- Analyst Count
- MOGU 0
- PMN 3
- Target Price
- MOGU N/A
- PMN $4.33
- AVG Volume (30 Days)
- MOGU 35.5K
- PMN 866.9K
- Earning Date
- MOGU 11-21-2025
- PMN 11-13-2025
- Dividend Yield
- MOGU N/A
- PMN N/A
- EPS Growth
- MOGU N/A
- PMN N/A
- EPS
- MOGU N/A
- PMN N/A
- Revenue
- MOGU $19,462,964.00
- PMN N/A
- Revenue This Year
- MOGU N/A
- PMN N/A
- Revenue Next Year
- MOGU N/A
- PMN N/A
- P/E Ratio
- MOGU N/A
- PMN N/A
- Revenue Growth
- MOGU N/A
- PMN N/A
- 52 Week Low
- MOGU $1.83
- PMN $0.38
- 52 Week High
- MOGU $8.10
- PMN $1.59
- Technical
- Relative Strength Index (RSI)
- MOGU 44.56
- PMN 48.38
- Support Level
- MOGU $3.05
- PMN $0.45
- Resistance Level
- MOGU $3.47
- PMN $0.61
- Average True Range (ATR)
- MOGU 0.22
- PMN 0.04
- MACD
- MOGU -0.08
- PMN 0.00
- Stochastic Oscillator
- MOGU 14.42
- PMN 38.37
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.